Thursday, 31 December 2009

Lotivas




Lotivas may be available in the countries listed below.


Ingredient matches for Lotivas



Lovastatin

Lovastatin is reported as an ingredient of Lotivas in the following countries:


  • Indonesia

International Drug Name Search

Sibutramine




In the US, Sibutramine (sibutramine systemic) is a member of the drug class anorexiants and is used to treat Obesity.

US matches:

  • Sibutramine

  • Sibutramine Hydrochloride

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A08AA10

CAS registry number (Chemical Abstracts Service)

0106650-56-0

Chemical Formula

C17-H26-Cl-N

Molecular Weight

279

Therapeutic Categories

Antiobesity agent

Serotonin and noradrenaline reuptake inhibitor

Chemical Name

Cyclobutanemethanamine, 1-(4-chlorophenyl)-N,N-dimethyl-α-(2-methylpropyl)-, (±)-

Foreign Names

  • Sibutraminum (Latin)
  • Sibutramin (German)
  • Sibutramine (French)
  • Sibutramina (Spanish)

Generic Names

  • Sibutramine (OS: BAN, DCF)
  • Sibutramine Hydrochloride (OS: USAN, BANM)
  • BTS 54524 (IS: Boots)

Brand Names

  • Adisar
    Roemmers, Peru


  • Atenix
    Medicamenta, Ecuador


  • Butramin
    Drug International, Bangladesh; Galeno, Colombia


  • Downtrat
    Dosa, Argentina


  • Ectiva
    Abbott, South Africa


  • Figur
    Farmacoop, Colombia


  • Ipogras
    Chile, Chile; Medco, Peru


  • Mesura
    ABL, Peru; Andromaco, Chile


  • Obestat
    Cipla, India


  • Redumin
    Osmopharm, Ecuador


  • Reduten
    Sanitas, Chile


  • Sacietyl
    Finadiet, Argentina


  • Saton
    Saval, Chile


  • Sibutram
    Euro, Dominican Republic


  • Sibutramina Genfar
    Genfar, Colombia; Genfar, Ecuador


  • Sibutramina La Santé
    La Santé, Colombia


  • Sibutramina MK
    McKesson, Ecuador; MK, Colombia


  • Sibutramina
    Elter - Medicamentos Genéricos, Venezuela; Medicalex, Colombia; OFA, Venezuela


  • Sibutramine-1A Pharma
    1A Pharma, Poland


  • Sibutrax
    Garmisch, Colombia


  • Adecid
    Armstrong, Mexico


  • Aderan
    Roemmers, Argentina


  • Adisar
    Pharma Investi, Chile


  • Afibron
    Teva, Poland


  • Atenix
    Tecnofarma, Chile


  • Betagen
    Newport, Costa Rica


  • Celtec
    Biogen, Colombia


  • Cetonid
    Gutis, Ecuador


  • Cetonil
    Gutis, Costa Rica; Gutis, Dominican Republic; Gutis, Nicaragua; Gutis, El Salvador


  • Controlex
    Bussié, Colombia; Bussié, Dominican Republic; Bussié, Guatemala; Bussié, Honduras; Bussié, Nicaragua; Bussié, Panama; Bussié, El Salvador


  • Delganex
    Ethical, Dominican Republic


  • Ectiva
    Abbott, Italy; Altana, Mexico


  • Formina
    Fluter, Dominican Republic


  • Gea
    Sandoz, Mexico


  • Ipomex
    Ivax, Argentina


  • Lindaxa
    Zentiva, Bulgaria; Zentiva, Czech Republic; Zentiva, Slovakia


  • Maxislim
    Sandoz, Indonesia


  • Medixil
    Rider, Chile


  • Meridia
    Abbott, Canada; Abbott, Czech Republic; Abbott, Georgia; Abbott, Poland; Abbott, Russian Federation; Abbott, United States


  • Milical
    Recalcine, Chile; Recalcine, Ecuador; Vivax, Venezuela


  • Mintagras
    Mintlab, Chile


  • Nor-kilos
    Teramed, El Salvador


  • Obenil
    Square, Bangladesh


  • Obirax
    Micro Labs, Dominican Republic; Micro Labs, Guatemala; Micro Labs, Myanmar; Micro Labs, Panama


  • Pimax
    HemCare, Dominican Republic


  • Plenty
    Procaps, Colombia


  • Raductil
    Abbott, Antigua & Barbuda; Abbott, Netherlands Antilles; Abbott, Aruba; Abbott, Barbados; Abbott, Bermuda; Abbott, Bahamas; Abbott, Costa Rica; Abbott, Grenada; Abbott, Guatemala; Abbott, Guyana; Abbott, Honduras; Abbott, Haiti; Abbott, Jamaica; Abbott, Cayman Islands; Abbott, Saint Lucia; Abbott, Mexico; Abbott, Nicaragua; Abbott, Panama; Abbott, Suriname; Abbott, El Salvador; Abbott, Turks & Caicos Islands; Abbott, Trinidad & Tobago; Abbott, Saint Vincent & The Grenadines; Abbott, Virgin Islands (British)


  • Reductil
    Abbott, United Arab Emirates; Abbott, Austria; Abbott, Australia; Abbott, Bosnia & Herzegowina; Abbott, Belgium; Abbott, Bulgaria; Abbott, Bahrain; Abbott, Brazil; Abbott, Chile; Abbott, Colombia; Abbott, Germany; Abbott, Denmark; Abbott, Estonia; Abbott, Egypt; Abbott, Spain; Abbott, Finland; Abbott, United Kingdom; Abbott, Hong Kong; Abbott, Croatia (Hrvatska); Abbott, Hungary; Abbott, Indonesia; Abbott, Ireland; Abbott, Iraq; Abbott, Iran; Abbott, Iceland; Abbott, Italy; Abbott, Jordan; Abbott, Kuwait; Abbott, Lebanon; Abbott, Lithuania; Abbott, Luxembourg; Abbott, Latvia; Abbott, Malta; Abbott, Malaysia; Abbott, Netherlands; Abbott, Norway; Abbott, New Zealand; Abbott, Oman; Abbott, Peru; Abbott, Philippines; Abbott, Portugal; Abbott, Qatar; Abbott, Romania; Abbott, Sudan; Abbott, Singapore; Abbott, Slovenia; Abbott, Slovakia; Abbott, Syria; Abbott, Thailand; Abbott, Turkey; Abbott, Taiwan; Abbott, Venezuela; Abbott, Yemen; Abbott, South Africa; Medcor, Netherlands; Teva, Israel


  • Reductimax
    Stein, Ecuador


  • Redux
    Unimed & Unihealth, Bangladesh


  • Reduxal
    Hexal, Dominican Republic


  • Repentil
    Nolver, Venezuela


  • Serotramin
    Medix, Mexico


  • Sibu
    Bouzen, Argentina


  • Sibulin
    Beximco, Bangladesh


  • Sibuthin
    ACI, Bangladesh


  • Sibutral
    Abbott, France


  • Sibutramin Sandoz
    Lek S.A., Bulgaria; Salutas Pharma, Bulgaria


  • Sibutramina Colmed
    Colmed, Colombia


  • Sibutramin-Teva
    Teva, Slovakia


  • Sibutrim
    Glenmark, Sri Lanka


  • Sibutrin
    General Pharma, Bangladesh


  • Siluval
    Valmor, Venezuela


  • Siruton
    Landsteiner, Mexico


  • Slim
    Rephco, Bangladesh


  • Vintix
    Roemmers, Venezuela


  • Zelium
    Eczacibasi, Turkey


  • Zelixa
    Biofarm, Poland

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday, 26 December 2009

Vitamine B1




Vitamine B1 may be available in the countries listed below.


Ingredient matches for Vitamine B1



Thiamine

Thiamine is reported as an ingredient of Vitamine B1 in the following countries:


  • Tunisia

International Drug Name Search

Wednesday, 23 December 2009

Isosorbidemononitraat Sandoz




Isosorbidemononitraat Sandoz may be available in the countries listed below.


Ingredient matches for Isosorbidemononitraat Sandoz



Isosorbide Mononitrate

Isosorbide Mononitrate is reported as an ingredient of Isosorbidemononitraat Sandoz in the following countries:


  • Netherlands

International Drug Name Search

Sunday, 20 December 2009

Triglyx




Triglyx may be available in the countries listed below.


Ingredient matches for Triglyx



Lamotrigine

Lamotrigine is reported as an ingredient of Triglyx in the following countries:


  • Czech Republic

International Drug Name Search

Monday, 7 December 2009

Siaten




Siaten may be available in the countries listed below.


Ingredient matches for Siaten



Eszopiclone

Zopiclone is reported as an ingredient of Siaten in the following countries:


  • Spain

International Drug Name Search

Friday, 4 December 2009

Erythromycinum Intravenosum




Erythromycinum Intravenosum may be available in the countries listed below.


Ingredient matches for Erythromycinum Intravenosum



Erythromycin

Erythromycin lactobionate (a derivative of Erythromycin) is reported as an ingredient of Erythromycinum Intravenosum in the following countries:


  • Poland

International Drug Name Search

Thursday, 3 December 2009

Saluron




In the US, Saluron (hydroflumethiazide systemic) is a member of the drug class thiazide diuretics and is used to treat Edema and High Blood Pressure.

US matches:

  • Saluron

Ingredient matches for Saluron



Hydroflumethiazide

Hydroflumethiazide is reported as an ingredient of Saluron in the following countries:


  • United States

International Drug Name Search

Tuesday, 1 December 2009

Tabergat




Tabergat may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Tabergat



Dimpylate

Dimpylate is reported as an ingredient of Tabergat in the following countries:


  • Portugal

Tetramethrin

Tetramethrin is reported as an ingredient of Tabergat in the following countries:


  • Portugal

International Drug Name Search

Thursday, 26 November 2009

Kesol




Kesol may be available in the countries listed below.


Ingredient matches for Kesol



Budesonide

Budesonide is reported as an ingredient of Kesol in the following countries:


  • Italy

International Drug Name Search

Haiprex




Haiprex may be available in the countries listed below.


Ingredient matches for Haiprex



Methenamine

Methenamine hippurate (a derivative of Methenamine) is reported as an ingredient of Haiprex in the following countries:


  • Denmark

  • Iceland

International Drug Name Search

Saturday, 21 November 2009

EnaHexal




EnaHexal may be available in the countries listed below.


Ingredient matches for EnaHexal



Enalapril

Enalapril is reported as an ingredient of EnaHexal in the following countries:


  • Vietnam

Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of EnaHexal in the following countries:


  • Australia

  • Bulgaria

  • Estonia

  • Georgia

  • Germany

  • Latvia

  • Lithuania

  • Romania

  • Serbia

International Drug Name Search

Thursday, 19 November 2009

Metafar




Metafar may be available in the countries listed below.


Ingredient matches for Metafar



Cefmetazole

Cefmetazole sodium salt (a derivative of Cefmetazole) is reported as an ingredient of Metafar in the following countries:


  • Italy

International Drug Name Search

Wednesday, 18 November 2009

Lamivir




Lamivir may be available in the countries listed below.


Ingredient matches for Lamivir



Lamivudine

Lamivudine is reported as an ingredient of Lamivir in the following countries:


  • Bangladesh

  • Ethiopia

  • Georgia

  • India

  • Venezuela

International Drug Name Search

Wednesday, 11 November 2009

Saturday, 7 November 2009

Sumatriptan FTAB




Sumatriptan FTAB may be available in the countries listed below.


Ingredient matches for Sumatriptan FTAB



Sumatriptan

Sumatriptan succinate (a derivative of Sumatriptan) is reported as an ingredient of Sumatriptan FTAB in the following countries:


  • Netherlands

International Drug Name Search

Friday, 6 November 2009

Enflocyna




Enflocyna may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Enflocyna



Enrofloxacin

Enrofloxacin is reported as an ingredient of Enflocyna in the following countries:


  • Poland

International Drug Name Search

Tuesday, 3 November 2009

Feiba




Ingredient matches for Feiba



Coagulation Factor VIII , Human (rDNA)

Coagulation Factor VIII , Human (rDNA) Octocog Alfa (a derivative of Coagulation Factor VIII , Human (rDNA)) is reported as an ingredient of Feiba in the following countries:


  • Bulgaria

Prothrombin Complex, Activated

Prothrombin Complex, Activated is reported as an ingredient of Feiba in the following countries:


  • Austria

  • Belgium

  • Croatia (Hrvatska)

  • Czech Republic

  • Denmark

  • Finland

  • France

  • Georgia

  • Germany

  • Hungary

  • Israel

  • Italy

  • Latvia

  • Lithuania

  • Malta

  • Serbia

  • Slovakia

  • Spain

  • Sweden

  • Turkey

  • United Kingdom

  • United States

International Drug Name Search

Monday, 2 November 2009

Fluocortolone Pivalate




Fluocortolone Pivalate may be available in the countries listed below.


Ingredient matches for Fluocortolone Pivalate



Fluocortolone

Fluocortolone Pivalate (BANM) is also known as Fluocortolone (Rec.INN)

International Drug Name Search

Glossary

BANMBritish Approved Name (Modified)
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday, 31 October 2009

Glipicontin




Glipicontin may be available in the countries listed below.


Ingredient matches for Glipicontin



Glipizide

Glipizide is reported as an ingredient of Glipicontin in the following countries:


  • India

International Drug Name Search

Wednesday, 21 October 2009

Nibiol




Nibiol may be available in the countries listed below.


Ingredient matches for Nibiol



Nitroxoline

Nitroxoline is reported as an ingredient of Nibiol in the following countries:


  • Taiwan

International Drug Name Search

Friday, 9 October 2009

Fleet Phospho-Soda




UK matches:

  • Fleet Phospho-Soda (SPC)

Ingredient matches for Fleet Phospho-Soda



Sodium Phosphate

Sodium Phosphate Dibasic (a derivative of Sodium Phosphate) is reported as an ingredient of Fleet Phospho-Soda in the following countries:


  • France

  • Greece

  • Indonesia

  • Malaysia

  • New Zealand

  • Singapore

  • Tunisia

  • Vietnam

Sodium Phosphate Dibasic dodecahydrate (a derivative of Sodium Phosphate) is reported as an ingredient of Fleet Phospho-Soda in the following countries:


  • Austria

  • Belgium

  • Germany

  • United Kingdom

  • United States

Sodium Phosphate Monobasic (a derivative of Sodium Phosphate) is reported as an ingredient of Fleet Phospho-Soda in the following countries:


  • Indonesia

  • New Zealand

  • Singapore

  • Vietnam

Sodium Phosphate Monobasic dihydrate (a derivative of Sodium Phosphate) is reported as an ingredient of Fleet Phospho-Soda in the following countries:


  • Austria

  • Belgium

  • Germany

  • United Kingdom

  • United States

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, 8 October 2009

Regitine


Generic Name: phentolamine (Injection route)

fen-TOL-a-meen

Commonly used brand name(s)

In the U.S.


  • OraVerse

  • Regitine

Available Dosage Forms:


  • Solution

  • Injectable

  • Powder for Solution

Therapeutic Class: Antihypertensive


Pharmacologic Class: Alpha-Adrenergic Blocker


Uses For Regitine


Phentolamine given by injection causes blood vessels to expand, thereby increasing blood flow. When injected into the penis (intracavernosal), it increases blood flow to the penis, which results in an erection.


This medicine should not be used as a sexual aid by men who do not have erectile dysfunction. If the medicine is not used properly, permanent damage to the penis and loss of the ability to have erections could result.


Phentolamine may also be used to reverse the effects of an anesthetic medicine in soft tissues, such as the lips and tongue. It may be used to help quickly restore normal sensation and function in patients who have received local dental anesthesia .


Phentolamine is available only with your doctor's prescription.


Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although this use is not included in product labeling, phentolamine is used in certain patients with the following medical conditions:


  • Low doses of a three-drug combination of phentolamine, papaverine, and alprostadil as an injection may be used to treat erectile dysfunction.

Before Using Regitine


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies have not been performed on the relationship of age to the effects of phentolamine for the reversal of soft-tissue anesthesia in children younger than 6 years of age. Safety and efficacy have not been established .


Geriatric


Many medicines have not been studied specifically in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults or if they cause different side effects or problems in older people. Although there is no specific information comparing the use of phentolamine for erectile dysfunction in the elderly, it is not expected to cause different side effects or problems in older people than it does in younger adults.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Tadalafil

Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Acebutolol

  • Alprenolol

  • Atenolol

  • Betaxolol

  • Bevantolol

  • Bisoprolol

  • Bucindolol

  • Carteolol

  • Carvedilol

  • Celiprolol

  • Dilevalol

  • Esmolol

  • Labetalol

  • Levobunolol

  • Mepindolol

  • Metipranolol

  • Metoprolol

  • Nadolol

  • Nebivolol

  • Oxprenolol

  • Penbutolol

  • Pindolol

  • Propranolol

  • Sotalol

  • Talinolol

  • Tertatolol

  • Timolol

  • Vardenafil

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Bleeding problems—These conditions increase the risk of bleeding at the place of injection.

  • Priapism (history of) or

  • Sickle cell disease—Patients with these conditions have an increased risk of priapism (erection lasting longer than 4 hours) while using phentolamine.

Proper Use of phentolamine

This section provides information on the proper use of a number of products that contain phentolamine. It may not be specific to Regitine. Please read with care.


To give the injection:


  • Cleanse the injection site with alcohol. Using a sterile needle, inject the medicine slowly and directly into the base of the penis as instructed by your doctor. It should not be injected just under the skin. The injection is usually not painful, although you may feel some tingling in the tip of your penis. If the injection is very painful or you notice bruising or swelling at the place of injection, that means you are injecting the medicine under the skin. Stop, withdraw the needle, and reposition it properly before continuing with the injection.

  • After you have completed the injection, put pressure on the place of injection to prevent bruising. Then massage your penis as instructed by your doctor. This helps the medicine spread to all parts of the penis, so that it will work better.

This medicine usually begins to work in about 10 minutes. You should attempt intercourse within 2 hours after injecting the medicine.


To reverse the effects of a soft-tissue anesthetic medicine, a dentist or other trained health professional will give you this medicine. This medicine is usually injected at the same spot where you have received the local dental anesthesia .


Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For injection dosage form:
    • For the treatment of impotence:
      • Adults— 0.5 to 1 milligram (mg) injected very slowly into the area of your penis as directed by your doctor. Allow one or two minutes to completely inject the dose. Do not inject more than one dose in a day. Also, do not use this medicine more than two days in a row or more than three times a week.



Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Precautions While Using Regitine


Use the injection exactly as directed by your doctor. Do not use more of it and do not use it more often than ordered. If too much is used, the erection may become so strong that it lasts too long and does not reverse when it should. This condition is called priapism, and it can be very dangerous. If the effect is not reversed, the blood supply to the penis may be cut off and permanent damage may occur.


Contact your doctor immediately if the erection lasts for longer than 4 hours or if it becomes painful. This may be a sign of priapism and must be treated right away to prevent permanent damage.


If you notice bleeding at the site when you inject the medicine, put pressure on the spot until the bleeding stops. If it doesn't stop, check with your doctor.


It is important for you to examine your penis regularly. Check with your doctor if you find a lump where the medicine has been injected or if you notice that your penis is becoming curved. These may be signs that unwanted tissue is growing (called fibrosis), which should be seen by your doctor.


Regitine Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


Rare
  • Dizziness

  • erection continuing for more than 4 hours, or painful erection

  • lumps in the penis

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


Less common or rare
  • Bruising or bleeding at place of injection

  • burning (mild) along penis

  • difficulty in ejaculating

  • swelling at place of injection

Phentolamine injected into the penis may cause tingling at the tip of the penis. This is no cause for concern.


Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Regitine side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Regitine resources


  • Regitine Side Effects (in more detail)
  • Regitine Use in Pregnancy & Breastfeeding
  • Regitine Drug Interactions
  • Regitine Support Group
  • 0 Reviews for Regitine - Add your own review/rating


  • Regitine Prescribing Information (FDA)

  • Phentolamine Prescribing Information (FDA)

  • Phentolamine Professional Patient Advice (Wolters Kluwer)

  • OraVerse Prescribing Information (FDA)

  • OraVerse Consumer Overview

  • Phentolamine Mesylate Monograph (AHFS DI)



Compare Regitine with other medications


  • Dermal Necrosis, Treatment
  • Pheochromocytoma
  • Pheochromocytoma Diagnosis

Monday, 5 October 2009

Flihaler




Flihaler may be available in the countries listed below.


Ingredient matches for Flihaler



Fluticasone

Fluticasone propionate (a derivative of Fluticasone) is reported as an ingredient of Flihaler in the following countries:


  • Greece

International Drug Name Search

Sunday, 4 October 2009

Linola-H N




Linola-H N may be available in the countries listed below.


Ingredient matches for Linola-H N



Prednisolone

Prednisolone is reported as an ingredient of Linola-H N in the following countries:


  • Germany

International Drug Name Search

Friday, 2 October 2009

Insimet




Insimet may be available in the countries listed below.


Ingredient matches for Insimet



Metformin

Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Insimet in the following countries:


  • Bangladesh

International Drug Name Search

Thursday, 1 October 2009

Zinecard




In the US, Zinecard (dexrazoxane systemic) is a member of the drug class miscellaneous uncategorized agents and is used to treat Cardiomyopathy Prophylaxis.

US matches:

  • Zinecard

Ingredient matches for Zinecard



Dexrazoxane

Dexrazoxane is reported as an ingredient of Zinecard in the following countries:


  • Canada

Dexrazoxane hydrochloride (a derivative of Dexrazoxane) is reported as an ingredient of Zinecard in the following countries:


  • United States

International Drug Name Search

Friday, 25 September 2009

Stanabolic




Stanabolic may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Stanabolic



Stanozolol

Stanozolol is reported as an ingredient of Stanabolic in the following countries:


  • Australia

International Drug Name Search

Monday, 21 September 2009

Colimycine




Colimycine may be available in the countries listed below.


Ingredient matches for Colimycine



Colistin Sulfate

Colistin is reported as an ingredient of Colimycine in the following countries:


  • Tunisia

Colistin sulfate (a derivative of Colistin) is reported as an ingredient of Colimycine in the following countries:


  • France

Colistin sulphomethate sodium (a derivative of Colistin) is reported as an ingredient of Colimycine in the following countries:


  • France

  • Slovakia

International Drug Name Search

Saturday, 19 September 2009

Estradot




In the US, Estradot is a member of the drug class estrogens and is used to treat Atrophic Urethritis, Atrophic Vaginitis, Breast Cancer - Palliative, Hypoestrogenism, Oophorectomy, Osteoporosis, Postmenopausal Symptoms, Primary Ovarian Failure and Prostate Cancer.

UK matches:

  • Estradot 25 micrograms/24 hours, transdermal patches (SPC)

Ingredient matches for Estradot



Estradiol

Estradiol is reported as an ingredient of Estradot in the following countries:


  • Australia

  • Canada

  • Luxembourg

  • Norway

  • South Africa

  • Spain

  • United Kingdom

Estradiol hemihydrate (a derivative of Estradiol) is reported as an ingredient of Estradot in the following countries:


  • Austria

  • Brazil

  • Estonia

  • Finland

  • Germany

  • Greece

  • Ireland

  • Luxembourg

  • Poland

  • Portugal

  • Slovakia

  • Sweden

  • Switzerland

  • Venezuela

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, 17 September 2009

Hipertil




Hipertil may be available in the countries listed below.


Ingredient matches for Hipertil



Captopril

Captopril is reported as an ingredient of Hipertil in the following countries:


  • Portugal

International Drug Name Search

Wednesday, 16 September 2009

Hoechst Rastinon




Hoechst Rastinon may be available in the countries listed below.


Ingredient matches for Hoechst Rastinon



Tolbutamide

Tolbutamide is reported as an ingredient of Hoechst Rastinon in the following countries:


  • Japan

International Drug Name Search

Thursday, 10 September 2009

Calcinate




Calcinate may be available in the countries listed below.


Ingredient matches for Calcinate



Calcium Pantothenate

Calcium Pantothenate is reported as an ingredient of Calcinate in the following countries:


  • Bangladesh

International Drug Name Search

Monday, 7 September 2009

Ameisensäure 60% ad us. vet.




Ameisensäure 60% ad us. vet. may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Ameisensäure 60% ad us. vet.



Formic Acid

Formic Acid is reported as an ingredient of Ameisensäure 60% ad us. vet. in the following countries:


  • Germany

International Drug Name Search

Sunday, 6 September 2009

Clindastad




Clindastad may be available in the countries listed below.


Ingredient matches for Clindastad



Clindamycin

Clindamycin hydrochloride (a derivative of Clindamycin) is reported as an ingredient of Clindastad in the following countries:


  • Germany

International Drug Name Search

Thursday, 3 September 2009

APC Sameko




APC Sameko may be available in the countries listed below.


Ingredient matches for APC Sameko



Aspirin

Acetylsalicylic Acid is reported as an ingredient of APC Sameko in the following countries:


  • Netherlands

Paracetamol

Paracetamol is reported as an ingredient of APC Sameko in the following countries:


  • Netherlands

International Drug Name Search

Tuesday, 1 September 2009

Levodopa C. comp. AbZ




Levodopa C. comp. AbZ may be available in the countries listed below.


Ingredient matches for Levodopa C. comp. AbZ



Carbidopa

Carbidopa monohydrate (a derivative of Carbidopa) is reported as an ingredient of Levodopa C. comp. AbZ in the following countries:


  • Germany

Levodopa

Levodopa is reported as an ingredient of Levodopa C. comp. AbZ in the following countries:


  • Germany

International Drug Name Search

Thursday, 27 August 2009

Extropect




Extropect may be available in the countries listed below.


Ingredient matches for Extropect



Ambroxol

Ambroxol hydrochloride (a derivative of Ambroxol) is reported as an ingredient of Extropect in the following countries:


  • Indonesia

International Drug Name Search

Ektebin




Ektebin may be available in the countries listed below.


Ingredient matches for Ektebin



Protionamide

Protionamide is reported as an ingredient of Ektebin in the following countries:


  • Germany

  • Romania

International Drug Name Search

Saturday, 22 August 2009

Femaplex




Femaplex may be available in the countries listed below.


Ingredient matches for Femaplex



Letrozole

Letrozole is reported as an ingredient of Femaplex in the following countries:


  • Greece

International Drug Name Search

Sunday, 16 August 2009

Multigram




Multigram may be available in the countries listed below.


Ingredient matches for Multigram



Tetracycline

Tetracycline hydrochloride (a derivative of Tetracycline) is reported as an ingredient of Multigram in the following countries:


  • Brazil

International Drug Name Search

Nafamostat Mesilate




Nafamostat Mesilate may be available in the countries listed below.


Ingredient matches for Nafamostat Mesilate



Nafamostat

Nafamostat Mesilate (JAN) is also known as Nafamostat (Rec.INN)

International Drug Name Search

Glossary

JANJapanese Accepted Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday, 15 August 2009

Diacan




Diacan may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Diacan



Dimpylate

Dimpylate is reported as an ingredient of Diacan in the following countries:


  • Portugal

Permethrin

Permethrin is reported as an ingredient of Diacan in the following countries:


  • Portugal

Piperonyl Butoxide

Piperonyl Butoxide is reported as an ingredient of Diacan in the following countries:


  • Portugal

International Drug Name Search

Saturday, 8 August 2009

Flunarizine Hydrochloride




Flunarizine Hydrochloride may be available in the countries listed below.


Ingredient matches for Flunarizine Hydrochloride



Flunarizine

Flunarizine Hydrochloride (BANM, JAN, USAN) is also known as Flunarizine (Rec.INN)

International Drug Name Search

Glossary

BANMBritish Approved Name (Modified)
JANJapanese Accepted Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday, 7 August 2009

Rotigotine


Pronunciation: roe-TIG-oh-teen
Generic Name: Rotigotine
Brand Name: Neupro


Rotigotine is used for:

Treating Parkinson disease.


Rotigotine is a dopamine agonist. It works in certain areas of the brain to reduce the symptoms (eg, tremor, uncontrolled muscle movements) of the early stages of Parkinson disease.


Do NOT use Rotigotine if:


  • you are allergic to any ingredient in Rotigotine

Contact your doctor or health care provider right away if any of these apply to you.



Before using Rotigotine:


Some medical conditions may interact with Rotigotine. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have heart problems (eg, heart failure, heart disease), blood vessel problems, high or low blood pressure, liver problems, kidney problems, lung problems, asthma, or a sleep disorder

  • if you smoke or have a personal or family history of addiction (eg, gambling, alcohol)

  • if you are scheduled to have magnetic resonance imaging (MRI) or a procedure to treat an irregular heartbeat (cardioversion)

Some MEDICINES MAY INTERACT with Rotigotine. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Benzodiazepines (eg, diazepam), medicines for mental or mood problems (eg, antidepressants, antipsychotics), or medicines for sleep (eg, zolpidem) because the risk of severe drowsiness may be increased

  • Dopamine antagonists (eg, phenothiazines) or metoclopramide because they may decrease Rotigotine's effectiveness

This may not be a complete list of all interactions that may occur. Ask your health care provider if Rotigotine may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Rotigotine:


Use Rotigotine as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • An extra patient leaflet is available with Rotigotine. Talk to your pharmacist if you have questions about this information.

  • Apply Rotigotine only to dry, intact skin on the upper torso, upper thigh, stomach, or outer surface of the upper arm as directed by your doctor or on the package labeling.

  • Do not apply Rotigotine to hairy, oily, irritated, broken, scarred, or calloused skin. If you must apply Rotigotine to a hairy area of skin, shave the hair from the area at least 3 days before you apply Rotigotine to that area.

  • Do not place the patch under tight clothing. Do not apply creams, lotions, ointments, oils, or powders to the skin where the patch will be applied. Never cut or tear the patch.

  • To use Rotigotine, gently wash the application site with soap and warm water. Rinse until all soap is removed. Dry the area with a clean, dry towel.

  • Remove the patch from its sealed pouch and peel away one side of the protective liner. Apply the sticky side of the patch to the skin. Peel away the rest of the liner so that the patch lies flat against the skin. There should be no bumps or folds in the patch. Press the patch against your skin firmly with the palm of your hand for 20 to 30 seconds to make sure there is good contact with the skin.

  • Wash your hands thoroughly with soap and water after applying Rotigotine. Do not touch your eyes until after you have washed your hands.

  • After 24 hours, remove the used patch and fold it in half with the sticky sides together. Discard out of the reach of children and away from pets. Wash the area with mild soap and warm water to remove any adhesive remaining on the skin. Apply a new patch to a different area of skin. Use a new application site each time you apply a new patch. Do not apply a patch to the same area of skin within 14 days.

  • If you have questions about how to use Rotigotine, check with your doctor or pharmacist.

  • Continue to use Rotigotine even if you feel well. Do not miss any doses.

  • If your patch falls off, apply a new patch for the rest of the day.

  • If you miss a dose of Rotigotine, remove the old patch and apply a new patch to a different area of skin. Go back to your regular dosing schedule. Do not wear 2 patches at once.

Ask your health care provider any questions you may have about how to use Rotigotine.



Important safety information:


  • Rotigotine may cause drowsiness or dizziness. These effects may be worse if you take it with alcohol or certain medicines. Use Rotigotine with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Do not drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using Rotigotine; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.

  • Some people who use Rotigotine may experience sudden onset of severe drowsiness or may even fall asleep during normal daily activities (eg, eating, talking, driving). This could occur without warning. If this happens, do not drive, operate machinery, or perform other possibly unsafe tasks while you use Rotigotine. Tell your doctor right away.

  • Some people have experienced new, unusual, or increased urges (eg, gambling, sexual urges) while using Rotigotine or other medicines used to treat Parkinson disease. Tell your doctor right away if you notice such effects.

  • Rotigotine may cause dizziness, lightheadedness, or fainting; alcohol, hot weather, exercise, or fever may increase these effects. To prevent them, sit up or stand slowly, especially in the morning. Sit or lie down at the first sign of any of these effects.

  • Do not apply heating pads, electric blankets, or other such sources of heat to the area where you apply Rotigotine. Avoid other sources of heat such as heat lamps; saunas; hot tubs; heated waterbeds; long, hot baths; or prolonged, direct exposure to sunlight while using Rotigotine. Heat may increase the amount of Rotigotine released into your skin.

  • Tell your doctor or dentist that you take Rotigotine before you receive any medical or dental care, emergency care, or surgery.

  • Remove Rotigotine from the skin before you have certain medical tests or treatments (eg, MRI, cardioversion). It may become hot and cause burns if left on the skin during such procedures.

  • Do not suddenly stop using Rotigotine without checking with your doctor. Doing so may cause withdrawal symptoms, including fever, confusion, muscle stiffness, and kidney problems.

  • Lab tests, including skin exams, may be performed while you use Rotigotine. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.

  • Use Rotigotine with caution in the ELDERLY; they may be more sensitive to its effects.

  • Rotigotine should be used with extreme caution in CHILDREN younger than 18 years old; safety and effectiveness in these children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Rotigotine while you are pregnant. It is not known if Rotigotine is found in breast milk. Do not breast-feed while taking Rotigotine.


Possible side effects of Rotigotine:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Back or joint pain; constipation; decreased appetite; dizziness; drowsiness; dry mouth; fatigue; headache; increased sweating; minor redness, swelling, or itching at the application site; nausea; trouble sleeping; upset stomach; vomiting.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); abnormal dreams; chest pain; confusion; difficult or decreased urination; fainting; fast, slow, or irregular heartbeat; fever; hallucinations; leg pain; loss of coordination; numbness or tingling of the skin; rigid muscles; sudden, severe drowsiness or falling asleep during normal daily activities; swelling of the arms or legs; trouble swallowing; unusual tiredness or weakness; vision changes.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Rotigotine side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include confusion; dizziness; hallucinations; nausea; seizures; unusual movements; vomiting.


Proper storage of Rotigotine:

Store Rotigotine at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store in the original packaging until just before use. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Rotigotine out of the reach of children and away from pets.


General information:


  • If you have any questions about Rotigotine, please talk with your doctor, pharmacist, or other health care provider.

  • Rotigotine is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Rotigotine. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Rotigotine resources


  • Rotigotine Side Effects (in more detail)
  • Rotigotine Use in Pregnancy & Breastfeeding
  • Rotigotine Drug Interactions
  • Rotigotine Support Group
  • 5 Reviews for Rotigotine - Add your own review/rating


  • rotigotine Transdermal Advanced Consumer (Micromedex) - Includes Dosage Information

  • Neupro Consumer Overview



Compare Rotigotine with other medications


  • Parkinson's Disease

Thursday, 6 August 2009

Ramatroban




Scheme

Rec.INN

Chemical Formula

C21-H21-F-N2-O4-S

Molecular Weight

416

Therapeutic Category

Antiplatelet agent, thromboxane receptor antagonist

Chemical Name

(+)-(3R)-3-(p-fluorobenzenesulfonamido)-1,2,3,4-tetrahydrocarbazole-9-propionic acid (WHO)

Foreign Names

  • Ramatrobanum (Latin)
  • Ramatroban (German)
  • Ramatroban (French)
  • Ramatrobán (Spanish)

Brand Name

  • Baynas
    Bayer Yakuhin, Japan

International Drug Name Search

Glossary

Rec.INNRecommended International Nonproprietary Name (World Health Organization)
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday, 4 August 2009

Duobetic




Duobetic may be available in the countries listed below.


Ingredient matches for Duobetic



Cromoglicic Acid

Cromoglicic Acid disodium salt (a derivative of Cromoglicic Acid) is reported as an ingredient of Duobetic in the following countries:


  • Greece

International Drug Name Search

Monday, 3 August 2009

Takkmint




Takkmint may be available in the countries listed below.


Ingredient matches for Takkmint



Trimetazidine

Trimetazidine dihydrochloride (a derivative of Trimetazidine) is reported as an ingredient of Takkmint in the following countries:


  • Japan

International Drug Name Search

Sunday, 2 August 2009

Labetalol HCl ratiopharm




Labetalol HCl ratiopharm may be available in the countries listed below.


Ingredient matches for Labetalol HCl ratiopharm



Labetalol

Labetalol hydrochloride (a derivative of Labetalol) is reported as an ingredient of Labetalol HCl ratiopharm in the following countries:


  • Netherlands

International Drug Name Search

Monday, 27 July 2009

Lignocaine + Chlorhexidine Catheter Lubricant




Lignocaine + Chlorhexidine Catheter Lubricant may be available in the countries listed below.


Ingredient matches for Lignocaine + Chlorhexidine Catheter Lubricant



Chlorhexidine

Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Lignocaine + Chlorhexidine Catheter Lubricant in the following countries:


  • New Zealand

Lidocaine

Lidocaine hydrochloride (a derivative of Lidocaine) is reported as an ingredient of Lignocaine + Chlorhexidine Catheter Lubricant in the following countries:


  • New Zealand

International Drug Name Search

Tuesday, 21 July 2009

Bromophed-DX


Generic Name: brompheniramine, dextromethorphan, and pseudoephedrine (brom fen EER a meen, dex troe me THOR fan, soo doe e FED rin)

Brand Names: Allanhist PDX Drops, Anaplex DM, Anaplex DMX, Andehist DM NR Syrup, Brom Tann, Bromaline DM, Bromdex D, Bromfed DM, Bromhist PDX, Bromhist-DM Drops, Bromophed-DX, Bromph DM, Bromplex DM, BroveX PSE DM, Dallergy DM, EndaCof-DM, Histacol BD Drops, Myphetane DX Cough, Neo DM, PBM Allergy, Pediahist DM Drops, ProHist DM, Q-Tapp DM, Resperal-DM Drops, Robitussin Allergy & Cough, Sildec DM


What is Bromophed-DX (brompheniramine, dextromethorphan, and pseudoephedrine)?

Brompheniramine is an antihistamine that reduces the effects of the natural chemical histamine in the body. Histamine can produce symptoms of sneezing, itching, watery eyes, and runny nose.


Dextromethorphan is a cough suppressant. It affects the signals in the brain that trigger cough reflex.


Pseudoephedrine is a decongestant that shrinks blood vessels in the nasal passages. Dilated blood vessels can cause nasal congestion (stuffy nose).


The combination of brompheniramine, dextromethorphan, and pseudoephedrine is used to treat runny or stuffy nose, sneezing, itching, watery eyes, cough, and sinus congestion caused by allergies, the common cold, or the flu.


This medicine will not treat a cough that is caused by smoking, asthma, or emphysema.

Brompheniramine, dextromethorphan, and pseudoephedrine may also be used for purposes not listed in this medication guide.


What is the most important information I should know about Bromophed-DX (brompheniramine, dextromethorphan, and pseudoephedrine)?


Do not give this medication to a child younger than 4 years old. Always ask a doctor before giving a cough or cold medicine to a child. Death can occur from the misuse of cough and cold medicines in very young children. You should not use this medication if you have severe constipation, a blockage in your stomach or intestines, or if you are unable to urinate. Do not use cough or cold medicine if you have untreated or uncontrolled diseases such as glaucoma, asthma or COPD, high blood pressure, heart disease, coronary artery disease, or overactive thyroid. Do not use cough or cold medicine if you have used an MAO inhibitor such as furazolidone (Furoxone), isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam, Zelapar), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects.

What should I discuss with my healthcare provider before taking Bromophed-DX (brompheniramine, dextromethorphan, and pseudoephedrine)?


Do not use cough or cold medicine if you have used an MAO inhibitor such as furazolidone (Furoxone), isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam, Zelapar), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects. You should not use this medication if you have severe constipation, a blockage in your stomach or intestines, or if you are unable to urinate. Do not use cough or cold medicine if you have untreated or uncontrolled diseases such as glaucoma, asthma or COPD, high blood pressure, heart disease, coronary artery disease, or overactive thyroid.

Ask a doctor or pharmacist if it is safe for you to take this medication if you have:



  • a blockage in your digestive tract (stomach or intestines), a colostomy or ileostomy;




  • diabetes;




  • liver or kidney disease;




  • epilepsy or other seizure disorder;




  • cough with mucus, or cough caused by emphysema or chronic bronchitis;




  • enlarged prostate or urination problems;




  • low blood pressure;




  • pheochromocytoma (an adrenal gland tumor); or




  • if you take potassium (Cytra, Epiklor, K-Lyte, K-Phos, Kaon, Klor-Con, Polycitra, Urocit-K).




FDA pregnancy category C. It is not known whether this medication will harm an unborn baby. Do not use cough or cold medicine without medical advice if you are pregnant. This medicine may pass into breast milk and may harm a nursing baby. Antihistamines and decongestants may also slow breast milk production. Do not use cough or cold medicine without medical advice if you are breast-feeding a baby.

How should I take Bromophed-DX (brompheniramine, dextromethorphan, and pseudoephedrine)?


Use exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended. Cough or cold medicine is usually taken only for a short time until your symptoms clear up.


Do not give this medication to a child younger than 4 years old. Always ask a doctor before giving a cough or cold medicine to a child. Death can occur from the misuse of cough and cold medicines in very young children.

Do not take for longer than 7 days in a row. Talk with your doctor if your symptoms do not improve after 7 days of treatment, or if you have a fever with a headache or skin rash.


Measure liquid medicine with a special dose-measuring spoon or medicine cup, not with a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one.


If you need surgery or medical tests, tell the surgeon or doctor ahead of time if you have taken a cough or cold medicine within the past few days. Store at room temperature away from moisture and heat. Do not freeze.

What happens if I miss a dose?


Since cough or cold medicine is taken when needed, you may not be on a dosing schedule. If you are taking the medication regularly, take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

Overdose symptoms may include severe forms of some of the side effects listed in this medication guide.


What should I avoid while taking Bromophed-DX (brompheniramine, dextromethorphan, and pseudoephedrine)?


This medicine may cause blurred vision and may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert and able to see clearly. Drinking alcohol can increase certain side effects of this medication. Ask a doctor or pharmacist before using any other cold, allergy, cough, or sleep medicine. Antihistamines, cough suppressants, and decongestants are contained in many combination medicines. Taking certain products together can cause you to get too much of a certain drug. Check the label to see if a medicine contains an antihistamine, cough suppressant, or decongestant.

Avoid taking this medication if you also take diet pills, caffeine pills, or other stimulants (such as ADHD medications). Taking a stimulant together with a decongestant can increase your risk of unpleasant side effects.


Avoid becoming overheated or dehydrated during exercise and in hot weather. This medication can decrease sweating and you may be more prone to heat stroke.

Bromophed-DX (brompheniramine, dextromethorphan, and pseudoephedrine) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat. Stop using this medicine and call your doctor at once if you have a serious side effect such as:

  • fast, slow, or uneven heart rate;




  • severe headache, mood changes, hallucinations;




  • severe dizziness or anxiety, feeling like you might pass out;




  • tremor, seizure (convulsions);




  • easy bruising or bleeding, unusual weakness;




  • fever;




  • urinating less than usual or not at all;




  • feeling short of breath; or




  • dangerously high blood pressure (severe headache, blurred vision, buzzing in your ears, anxiety, confusion, chest pain, uneven heartbeats, seizure).



Less serious side effects may include:



  • mild headache;




  • mild dizziness, drowsiness;




  • dry mouth, nose, or throat;




  • nausea, diarrhea, constipation, upset stomach;




  • feeling nervous, restless, or irritable;




  • blurred vision; or




  • sleep problems (insomnia).



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Bromophed-DX (brompheniramine, dextromethorphan, and pseudoephedrine)?


Ask a doctor or pharmacist before using this medicine if you regularly use other medicines that make you sleepy (such as narcotic pain medication, sedatives, sleeping pills, muscle relaxers, and medicine for seizures, depression or anxiety). They can add to sleepiness caused by brompheniramine or dextromethorphan.


Ask a doctor or pharmacist if it is safe for you to take this medication if you are also using any of the following drugs:



  • atropine (Atreza, Sal-Tropine);




  • benztropine (Cogentin);




  • topiramate (Topamax);




  • zonisamide (Zonegran);




  • an antidepressant such as citalopram (Celexa), duloxetine (Cymbalta), escitalopram (Lexapro), fluoxetine (Prozac, Sarafem, Symbyax), paroxetine (Paxil, Pexeva), sertraline (Zoloft), venlafaxine (Effexor), and others;




  • anti-nausea medications such as belladonna (Donnatal), dimenhydrinate (Dramamine), droperidol (Inapsine), methscopolamine (Pamine), or scopolamine (Transderm Scop);




  • bladder or urinary medications such as darifenacin (Enablex), flavoxate (Urispas), oxybutynin (Ditropan, Oxytrol), solifenacin (Vesicare), tolterodine (Detrol), or Urogesic Blue;




  • bronchodilators such as ipratropium (Atrovent) or tiotropium (Spiriva);




  • irritable bowel medications such as dicyclomine (Bentyl), hyoscyamine (Hyomax), or propantheline (Pro Banthine); or




  • ulcer medicine such as glycopyrrolate (Robinul) or mepenzolate (Cantil).



This list is not complete and other drugs may interact with brompheniramine, dextromethorphan, and pseudoephedrine. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



More Bromophed-DX resources


  • Bromophed-DX Use in Pregnancy & Breastfeeding
  • Bromophed-DX Drug Interactions
  • Bromophed-DX Support Group
  • 0 Reviews for Bromophed-DX - Add your own review/rating


  • Anaplex DMX Suspension MedFacts Consumer Leaflet (Wolters Kluwer)

  • Bromdex D Prescribing Information (FDA)

  • Bromfed DM Elixir MedFacts Consumer Leaflet (Wolters Kluwer)

  • Bromfed DM Prescribing Information (FDA)

  • Myphetane DX Prescribing Information (FDA)

  • Neo DM Suspension MedFacts Consumer Leaflet (Wolters Kluwer)

  • Resperal-DM Drops MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Bromophed-DX with other medications


  • Cough and Nasal Congestion


Where can I get more information?


  • Your pharmacist can provide more information about brompheniramine, dextromethorphan, and pseudoephedrine.


Abacavir




In the US, Abacavir (abacavir systemic) is a member of the drug class nucleoside reverse transcriptase inhibitors (NRTIs) and is used to treat HIV Infection and Nonoccupational Exposure.

US matches:

  • Abacavir

  • Abacavir Solution

  • Abacavir/Lamivudine

  • Abacavir/Lamivudine/Zidovudine

  • Abacavir and lamivudine

  • Abacavir, lamivudine, and zidovudine

  • Abacavir-lamivudine-zidovudine

  • Abacavir Sulfate

  • Abacavir Sulfate/Lamivudine

  • Abacavir Sulfate/Lamivudine/Zidovudine

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AF06

CAS registry number (Chemical Abstracts Service)

0136470-78-5

Chemical Formula

C14-H18-N6-O

Molecular Weight

286

Therapeutic Category

Antiviral agent, HIV reverse transcriptase inhibitor

Chemical Names

(1S,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol (WHO)

(1S,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-methanol (IUPAC)

2-Cyclopentene-1-methanol, 4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-

Foreign Names

  • Abacavirum (Latin)
  • Abacavir (German)
  • Abacavir (French)
  • Abacavir (Spanish)

Generic Names

  • Abacavir (OS: BAN, DCF)
  • Abacavir Sulfate (OS: USAN)
  • Abacavir Sulphate (2:1) (OS: BANM)
  • 1592 U 89 sulfate (IS: GlaxoWellcome)
  • Abacavir Sulfate (PH: Ph. Int. 4)

Brand Names

  • Abacavir Elea
    Elea, Argentina


  • Endocare
    Farmacare, Peru


  • Kivexa (Abacavir and Lamivudine)
    Glaxo Group, Austria; GlaxoSmithKline, Slovenia


  • Trizivir
    GlaxoSmithKline, Czech Republic


  • Trizivir (Abacavir and Lamivudine, + Zidovudine)
    Glaxo SmithKline, Spain


  • Ziagen
    Glaxo Wellcome, Tunisia; GlaxoGroup, Netherlands; GlaxoSmithKline, Colombia; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Peru; GlaxoSmithKline, Turkey; GlaxoSmithKline, Taiwan; GlaxoSmithKline, South Africa


  • Abamune
    Biotoscana, Colombia; Cipla, India


  • Epzicom (Abacavir and Lamivudine)
    GlaxoSmithKline, Japan; ViiV Healthcare, United States


  • Filabac
    Filaxis, Argentina


  • Kivexa (Abacavir and Lamivudine)
    Glaxo SmithKline, Spain; GlaxoGroup, Netherlands; GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Canada; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Greece; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Hungary; GlaxoSmithKline, Ireland; GlaxoSmithKline, Italy; GlaxoSmithKline, Norway; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Portugal; GlaxoSmithKline, Sweden; GlaxoSmithKline, South Africa; ViiV, Switzerland


  • Plusabcir
    Dosa, Argentina


  • Trizivir (Abacavir and Lamivudine, + Zidovudine)
    Glaxo Group, Austria; Glaxo Wellcome, Bulgaria; GlaxoGroup, Netherlands; GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Canada; GlaxoSmithKline, Colombia; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Ireland; GlaxoSmithKline, Norway; GlaxoSmithKline, Oman; GlaxoSmithKline, Sweden; GlaxoSmithKline, Turkey; GlaxoSmithKline, South Africa; Shire, Canada; ViiV, Switzerland; ViiV Healthcare, United States


  • Zepril
    Richmond, Argentina


  • Ziagen
    Glaxo Group, Austria; Glaxo Group, Luxembourg; Glaxo SmithKline, Spain; Glaxo Wellcome, Slovenia; GlaxoGroup, Netherlands; GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Canada; GlaxoSmithKline, Chile; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, Finland; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Greece; GlaxoSmithKline, Guyana; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Ireland; GlaxoSmithKline, Israel; GlaxoSmithKline, Iceland; GlaxoSmithKline, Italy; GlaxoSmithKline, Japan; GlaxoSmithKline, Norway; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Oman; GlaxoSmithKline, Romania; GlaxoSmithKline, Serbia; GlaxoSmithKline, Russian Federation; GlaxoSmithKline, Sweden; GlaxoSmithKline, Singapore; GlaxoSmithKline, Slovakia; GlaxoSmithKline, Venezuela; ViiV, Switzerland; ViiV Healthcare, United States


  • Ziagenavir
    GlaxoSmithKline, Argentina; GlaxoSmithKline, Brazil; GlaxoSmithKline, Mexico; GlaxoSmithKline, Thailand

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.